The Journal of International Advanced Otology
Case Report

Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant

1.

Department of Otolaryngology-Head and Neck Surgery, Seoul National University School of Medicine, Seoul, Republic of Korea

J Int Adv Otol 2018; 14: 144-147
DOI: 10.5152/iao.2018.4517
Read: 12 Downloads: 2 Published: 03 September 2019

Abstract

Eosinophilic otitis media (EOM) are intractable otitis media characterized by highly viscous secretions containing eosinophils in the middle ear. They are resistant to conventional medication and surgery. This condition occurs primarily in patients with bronchial asthma or allergic rhinitis and is often complicated by rhinosinusitis. Systemic and topical steroid therapies are effective treatments. However, long-term steroid therapy is often limited by a high risk of serious adverse effects. The use of topical steroids and otorrhea are bothersome when wearing hearing aids. Here, we report a case of intractable otitis media due to EOM. Otorrhea was controlled with topical steroids. Bone conduction hearing was stable for an extended period with anti-IgE monoclonal antibodies (omalizumab). An implantable bone conduction hearing aid was used for rehabilitation of conductive hearing loss.

 

Cite this article as: Han YE, Kang YS, Cho Y, Park MK. Eosinophilic Otitis Media Treated with Anti-IgE Monoclonal Antibodies and A Bone Conduction Implant. J Int Adv Otol 2018; 14(1): 144-7.

Files
ISSN1308-7649 EISSN 2148-3817